In Vitro and In Vivo Efficacies of the New Triazole Albaconazole against Cryptococcus neoformans

The activity of albaconazole (UR-9825; J. Uriach & Cía. S.A., Barcelona, Spain) was compared to that of fluconazole against 12 isolates of Cryptococcus neoformans in vitro and against 1 isolate in vivo in a rabbit model of cryptococcal meningitis. Albaconazole was 100-fold more potent in vitro than...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Miller, J. L., Schell, W. A., Wills, E. A., Toffaletti, D. L., Boyce, M., Benjamin, D. K., Bartroli, J., Perfect, J. R.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2004
主題:	Experimental Therapeutics
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC321550/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14742184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.2.384-387.2004
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!